✦ LIBER ✦

The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: The first clinical candidate

✍ Scribed by Jane L. Wang; Jeffery Carter; James R. Kiefer; Ravi G. Kurumbail; Jennifer L. Pawlitz; David Brown; Susan J. Hartmann; Matthew J. Graneto; Karen Seibert; John J. Talley

Book ID: 104004659
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 660 KB
Volume: 20
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2010.07.053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The novel benzopyran class of selective

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: The three microdose candidates

✍ Jane L. Wang; Karl Aston; David Limburg; Cindy Ludwig; Ann E. Hallinan; Francis 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 742 KB

ChemInform Abstract: The Novel Benzopyra

ChemInform Abstract: The Novel Benzopyran Class of Selective Cyclooxygenase-2- Inhibitors. Part 3. The Three Microdose Candidates.

✍ Jane L. Wang; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

The novel benzopyran class of selective

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life

✍ Jane L. Wang; David Limburg; Matthew J. Graneto; John Springer; Joseph Rogier Br 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 811 KB

In this Letter, we provide the structure-activity relationships, optimization of design, testing criteria, and human half-life data for a series of selective COX-2 inhibitors. During the course of our structure-based drug design efforts, we discovered two distinct binding modes within the COX-2 acti

Correction to Selective Class I Phosphoi

Correction to Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511

✍ Norman, Mark H.; Andrews, Kristin L.; Bo, Yunxin Y.; Booker, Shon K.; Caenepeel, 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 112 KB

Correction to Discovery of a Novel Class

Correction to Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1 H -[1,2,3]triazolo[4,5- b ]pyrazin-6-yl)-1 H -pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer

✍ Cui, J. Jean; McTigue, Michele; Nambu, Mitchell; Tran-Dubé, Michelle; Pairish, M 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 124 KB

Discovery of a Novel Class of Phosphodie

Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia † † Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).

✍ Verhoest, Patrick R.; Chapin, Douglas S.; Corman, Michael; Fonseca, Kari; Harms, 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 1015 KB